Ryaltris: Your combination to offer patients relief from the symptoms of Allergic Rhinitis - Fast 1-4
*NEW fixed dose combination of mometasone furoate and olopatadine hydrochloride indicated for symptomatic treatment of seasonal or perennial allergic rhinitis and associated ocular symptoms in adults and children of 6 years and older.
i TNSS: p,0.05 vs placebo. §0.52 change in average rTOSS va placebo(p<0.001). ‡Low rates of adverse events up to 52 weeks. 1. Ryaltris Approved Product Information. 2. Gross GN et al. Ann Allergy Asthma Immunol 2019;122:630-638. 3. Hampel FC et al. Allergy Asthma Proc 2019;40(4):261-272. 4. Segall N et al. Allergy Asthma Proc 2019;40(5):301-310. iTNSS: instantaneous Total Nasal Symptom Score rTNSS: reflective total nasal symptom score. rTOSS: reflective total ocular symptom score.